Cohen Klingenstein LLC

Holdings History for GLAXOSMITHKLINE PLC - ADR (GSK)

Symbol: GSK on NYSE
Investment type: Equity / ADR

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2022		-0.46%	$0	0	-211,500	-100%	$49.04	Q3 2022
30 Jun 2022	0.46%	0%	$9,207,000	211,500	0		$43.53	Q2 2022
31 Mar 2022	0.38%	0%	$9,213,000	211,500	0		$43.56	Q1 2022
31 Dec 2021	0.37%	-0.09%	$9,327,000	211,500	-50,000	-19%	$44.10	Q4 2021
30 Sep 2021	0.44%	-0.01%	$9,992,000	261,500	-7,230	-2.7%	$38.21	Q3 2021
30 Jun 2021	0.46%	0%	$10,701,000	268,730	0		$39.82	Q2 2021
31 Mar 2021	0.44%	0%	$9,591,000	268,730	0		$35.69	Q1 2021
31 Dec 2020	0.49%	0%	$9,889,000	268,730	0		$36.80	Q4 2020
30 Sep 2020	0.57%	0%	$10,115,000	268,730	0		$37.64	Q3 2020
30 Jun 2020	0.67%	0%	$10,961,000	268,730	0		$40.79	Q2 2020
31 Mar 2020	0.75%	0%	$10,182,000	268,730	0		$37.89	Q1 2020
31 Dec 2019	0.73%	0%	$12,628,000	268,730	0		$46.99	Q4 2019
30 Sep 2019	0.72%	+0.07%	$11,469,000	268,730	+26,000	+11%	$42.68	Q3 2019
30 Jun 2019	0.69%	-0.07%	$9,714,000	242,730	-26,000	-9.7%	$40.02	Q2 2019
31 Mar 2019	0.78%	+0.34%	$11,230,000	268,730	+116,000	+76%	$41.79	Q1 2019
31 Dec 2018	0.88%	0%	$5,836,000	152,730	0		$38.21	Q4 2018
30 Sep 2018	0.78%	0%	$6,135,000	152,730	0		$40.17	Q3 2018
30 Jun 2018	0.84%	0%	$6,157,000	152,730	0		$40.31	Q2 2018
31 Mar 2018	0.85%	0%	$5,967,000	152,730	0		$39.07	Q1 2018
31 Dec 2017	0.77%	0%	$5,417,000	152,730	0		$35.47	Q4 2017
30 Sep 2017	0.94%	0%	$6,201,000	152,730	0		$40.60	Q3 2017
30 Jun 2017	1%	0%	$6,586,000	152,730	0		$43.12	Q2 2017
31 Mar 2017	1%	0%	$6,439,000	152,730	0		$42.16	Q1 2017
31 Dec 2016	1%	0%	$5,882,000	152,730	0		$38.51	Q4 2016
30 Sep 2016	1.1%	0%	$6,587,000	152,730	0		$43.13	Q3 2016
30 Jun 2016	1.2%	0%	$6,619,000	152,730	0		$43.34	Q2 2016
31 Mar 2016	1.2%	0%	$6,193,000	152,730	0		$40.55	Q1 2016
31 Dec 2015	1.1%	0%	$6,163,000	152,730	0		$40.35	Q4 2015
30 Sep 2015	1.2%	0%	$5,872,000	152,730	0		$38.45	Q3 2015
30 Jun 2015	1.1%	0%	$6,361,000	152,730	0		$41.65	Q2 2015
31 Mar 2015	1.3%	0%	$7,048,000	152,730	0		$46.15	Q1 2015
31 Dec 2014	1.2%	0%	$6,528,000	152,730	0		$42.74	Q4 2014
30 Sep 2014	1.2%	0%	$7,021,000	152,730	0		$45.97	Q3 2014
30 Jun 2014	1.6%	0%	$8,168,000	152,730	0		$53.48	Q2 2014
31 Mar 2014	1.6%	0%	$8,160,000	152,730	0		$53.43	Q1 2014
31 Dec 2013	1.6%	0%	$8,154,000	152,730	0		$53.39	Q4 2013

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.